Abstract
PCN9 - Factors Influencing the Pharmacokinetics of Sunitinib and its Active Metabolite in MRCC Patients Receiving an Attenuated Sunitinib Dosing Regimen
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have